News
MEDS
2.230
-3.04%
-0.070
DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network
Benzinga · 2d ago
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
Barchart · 2d ago
Datavault signs non-binding LOI to acquire 19.9% stake in DataMEDS AI
TipRanks · 3d ago
Datavault AI signs LOI to acquire 19.9% stake in DataMEDS AI
Seeking Alpha · 3d ago
DataMEDS AI enters amended, restated LOI to license, acquire IP
TipRanks · 3d ago
DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042
Benzinga · 3d ago
DataMeds AI Regains Nasdaq Equity Compliance Status
TipRanks · 5d ago
DataMeds AI Regains Compliance With Nasdaq Equity Rule
Benzinga · 5d ago
DataMeds Regains Compliance With NASDAQ Listing Standards
Barchart · 5d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 6d ago
Weekly Report: what happened at MEDS last week (1012-1016)?
Weekly Report · 6d ago
DataMeds AI Licenses REBOOT Platform, Issues Equity
TipRanks · 10/16 21:52
DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component
Benzinga · 10/16 21:23
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Barchart · 10/16 05:00
DataMeds AI To Collaborate With REBOOT Health AI To Integrate Its GLP Management Platform Into Its Health Lives Here Mobile App Under License Agreement
Benzinga · 10/14 13:50
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Barchart · 10/14 08:48
DataMeds AI Restructures Equity and Forms Licensing Partnership
TipRanks · 10/13 21:48
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Barchart · 10/13 05:00
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
Benzinga · 10/12 16:00
DataMeds' Helomics Secures Humana Medicaid Coverage For ChemoFx Cancer Assay; Stock Up
NASDAQ · 10/12 13:10
More
Webull provides a variety of real-time MEDS stock news. You can receive the latest news about Datameds AI Inc through multiple platforms. This information may help you make smarter investment decisions.
About MEDS
DataMeds AI, Inc., formerly Wellgistics Health, Inc., is a holding company. It is engaged in health information technology (IT) that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units. The Company conducts its business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC, and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows clinical services to be connected to its health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, prescription price transparency, and provide additional concierge services.